Bauhinia forficata (Beef shank) : medicinal properties | Lapo

Bauhinia forficata (Beef shank) : medicinal properties in alcoholic extraction
Bauhinia forficata (Beef shank) — family Caesalpiniacées.
This database documents alcoholic (ethanol) extractions of active substances. Our monograph currently lists 6 indications in alcoholic extraction for this species. The monograph draws on 34 scientific references recorded for the species.
Therapeutic indications in alcoholic extraction:
Note: scientific reference excerpts are kept in their original language (most often English), without translation, to respect the source text of publications.
- Type II diabetes mellitus : Plant part used: Sheet. Documented pharmacological profile: Glibenclamide-like, Metformine-like.
According to De Souza C (2004): The antidiabetic activity of aqueous, ethanolic & hexanic extracts of Bauhinia forficata was investigated in a model of alloxan-induced diabetes in rats. The alloxan-diabetic rats showed significant reductions in plasma glucose, triglycerides, total cholesterol & HDL-cholesterol after treatment with the extracts & Glibenclamide (used as standard) as compared to the diabetic controls. According to Barreto-Silva FRM (2002): Treatment of normal & alloxan-induced diabetic rats with BF decreased glucose levels, while this fraction was devoid of hypoglycemic effect in glucose-fed hyperglycemic normal rats. - Type 1 diabetes mellitus : Plant part used: Sheet. Documented pharmacological profile: Insuline-like.
According to De Souza C (2004): The antidiabetic activity of aqueous, ethanolic & hexanic extracts of Bauhinia forficata was investigated in a model of alloxan-induced diabetes in rats. The alloxan-diabetic rats showed significant reductions in plasma glucose, triglycerides, total cholesterol & HDL-cholesterol after treatment with the extracts & Glibenclamide (used as standard) as compared to the diabetic controls. According to Barreto-Silva FRM (2002): Treatment of normal & alloxan-induced diabetic rats with BF decreased glucose levels, while this fraction was devoid of hypoglycemic effect in glucose-fed hyperglycemic normal rats. - Type II : Plant part used: Sheet. Documented pharmacological profile: Glibenclamide-like, Metformine-like, Glibenclamide-like, Metformine-like.
According to De Souza C (2004): The antidiabetic activity of aqueous, ethanolic & hexanic extracts of Bauhinia forficata was investigated in a model of alloxan-induced diabetes in rats. The alloxan-diabetic rats showed significant reductions in plasma glucose, triglycerides, total cholesterol & HDL-cholesterol after treatment with the extracts & Glibenclamide (used as standard) as compared to the diabetic controls. According to Barreto-Silva FRM (2002): Treatment of normal & alloxan-induced diabetic rats with BF decreased glucose levels, while this fraction was devoid of hypoglycemic effect in glucose-fed hyperglycemic normal rats.
Further indications (including other extraction modes where applicable), dosages, precautions for use and full scientific references are available in the complete monograph.
Lapotitjéri di la Nati medicinal database
Ethanolic extracts of active substances — monographs, indications, dosages and references for healthcare professionals. Ethnopharmacologist Emmanuel Nossin.
→ Search Bauhinia forficata in the database (subscription required)
Photo credit : Photo by Franz Xaver without modification (CC BY 4.0). License : CC BY 4.0.
